Lifemd Inc LFMD

$2.72 -0.02 (-0.73%)

Valuation

Market cap
132,071,000
Revenue TTM
$194,060,000
Net income TTM
$14,350,000
PE ratio
0.00
Forward PE
—
Profit margin
7.39%
Debt to equity
0.00

Trading

Volume
802,500
Avg volume
892,264
Day's range
$2.67 – $2.86
Shares out
48,201,000
Stochastic %K
8%
Beta
1.99
Analysts
Strong Sell
Price target
$8.12

Price

Company profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss...

Show more

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Industry
Health Information Services
Sector
Healthcare
Phone
866 351 5907
Website
https://lifemd.com
Address
236 Fifth Avenue, Suite 400, New York, United States

Latest news

Stocktwits

T00thDr88 Oct 6, 1:39 PM
$LFMD people might actually save money on food and grocery bill paying the monthly cost for weight loss drugs. This might be one of the greatest marketing campaigns or ideas for LifeMD. High Inflation? Don’t fret, get Ozempic!
0 replies
thejman1 Oct 5, 3:31 PM
$LFMD end of year probably under 2 dollars.
0 replies
B2iDigital Oct 2, 11:54 PM
Rocket Doctor AI Inc. (CSE: AIDR | OTC: $AIRDF | FRA: 939) will present on October 7, 2026 at the National Investment Banking Association (NIBA) 153rd Investment Conference at The Westin Fort Lauderdale Beach Resort in Fort Lauderdale, Florida. The conference runs October 6-7, with company presentations on October 7 and one-on-one meetings with the presenting companies that afternoon. Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company’s in-depth profile at: https://b2idigital.com/rocket-doctor-inc-1 Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 800,000 patient visits. Since 1982, NIBA has been serving the micro-cap and small-cap investment community. See the conference details and presenting companies: https://b2idigital.com/niba-153rd-investment-conference Register to attend: https://nibanet.org/attendee-registration-and-information/ B2i Digital, The Capital Markets Matchmaker℠, carries each presenting company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $LFMD, $TALK, $CLOV, $IHF
1 replies
thejman1 Oct 2, 10:26 PM
$LFMD less and less people on the site or app every month. company burning cash like mad when they stopped advertising. they have the infrastructure all ready. yet company still isnt profitable. gj.
0 replies
B2iDigital Oct 1, 7:09 PM
Rocket Doctor AI Inc. (CSE: AIDR, OTC: $AIRDF , Frankfurt: 939) said in an October 1 release that Dr. William Cherniak, Founder and CEO of its wholly owned subsidiary Rocket Doctor Inc., will present live at the 2026 CANTech Letter Conference in Toronto on Thursday, October 8, 2026. Dr. Cherniak will use the session to give attendees an overview of the company's platform, solutions, recent milestones and growth strategy. Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/rocket-doctor-inc-1 The session will put Rocket Doctor AI before an annual Toronto conference that attracts a broad audience of investors: • The presentation runs from 4:00 to 4:30 p.m. ET in Track 2 of the conference in Toronto, Ontario • The conference brings together innovative Canadian companies across technology, healthcare, AI, cybersecurity, fintech and diversified industries • Its audience includes institutional investors and retail tech-focused investors seeking exposure to emerging Canadian investment ideas • Event details and registration are available at conference.cantechletter.com Regarding the conference and his presentation, Dr. William Cherniak, Founder and CEO of Rocket Doctor Inc., commented: "CANTech brings together Canada’s most engaged technology investors and operators. I am excited to share how Rocket Doctor AI is deploying clinician-led, pragmatic AI platforms to streamline workflows, reduce administrative friction, and ultimately improve patient access and outcomes." Read the full release: https://www.globenewswire.com/news-release/2026/10/01/3372842/0/en/rocket-doctor-ai-to-present-at-the-2026-cantech-letter-conference-in-toronto.html Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 800,000 patient visits. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $LFMD, $TALK, $CLOV, $IHF
1 replies
B2iDigital Sep 30, 8:23 PM
Rocket Doctor AI Inc. (CSE: $AIDR, OTC: AIRDF, Frankfurt: 939) will present live on October 7, 2026 at the National Investment Banking Association (NIBA)'s 153rd Investment Conference in Fort Lauderdale, Florida, the company announced on September 30. CEO Dr. Essam Hamza will deliver a high-level overview of the company's highlights, platform, recent milestones and growth strategy. Rocket Doctor AI Inc. is a B2i Digital Featured Company. See the company's in-depth profile at: https://b2idigital.com/rocket-doctor-inc-1 Ahead of the October 7 presentation, Rocket Doctor AI has published two September operating updates that carry its most recent reported figures: • The September 1 results release reported second quarter 2026 revenue of C$734,028, up 43% year over year from C$512,756 in Q2 2025 • Completed U.S. patient visits rose to 3,911 in Q2 2026 from 1,319 in Q1 2026, while the active clinician network expanded from 19 to 30 • In the September 14 operational update, the two months ending August 31, 2026 produced 3,625 completed U.S. patient visits, 93% of the 3,911 recorded across the entire second quarter NIBA is a non-profit organization that has been serving the micro-cap and small-cap investment community for almost 50 years. Regarding the Fort Lauderdale conference, Dr. Essam Hamza, CEO of Rocket Doctor AI, stated: "This event offers a fantastic opportunity to overview Rocket Doctor AI’s growth story and strategy, as well as connecting with market leading investment professionals, financing partners, and market makers." Read the full release: https://www.globenewswire.com/news-release/2026/09/30/3371828/0/en/rocket-doctor-ai-to-present-at-the-153rd-national-investment-banking-association-niba-conference-in-florida.html Rocket Doctor AI Inc. delivers physician-guided, AI-powered solutions built to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of its proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide, alongside a digital health platform and marketplace that has helped more than 350 physicians support over 800,000 patient visits. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer. $LFMD, $TALK, $CLOV, $IHF
1 replies
MarioAndretti Sep 30, 12:27 AM
$LFMD The pots a brewing any fucking day we gonna creep out of the sewers and fly into the sky like an eagle chasing its prey
0 replies
Phil1973 Sep 29, 9:29 PM 0 replies